VeriMomanthemis nobilis flower extract hamilelikte güvenli mi?
No harmonised CLP reproductive classification for Anthemis nobilis flower extract (ECHA Annex VI has no H360/H361 entry). Regulatory/industry safety assessments and databases (CIR/SCCS absence of adverse flags; EWG lists chamomile as low concern) and lack of published in vivo reproductive toxicity for the extract support no identified reproductive hazard. Topical dermal exposure can result in low but measurable absorption for herbal extracts, so exposure scored as low (adult). Sources: ECHA Annex VI (no harmonised classification), CIR (no reproductive safety restriction), PubChem/ECHA dossiers, EWG.
Pregnancy-safe products containing anthemis nobilis flower extract
Related ingredients
Frequently asked questions
- anthemis nobilis flower extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classification for Anthemis nobilis flower extract (ECHA Annex VI has no H360/H361 entry). Regulatory/industry safety assessments and databases (CIR/SCCS absence of adverse flags; EWG lists chamomile as low concern) and lack of published in vivo reproductive toxicity for the extract support no identified reproductive hazard. Topical dermal exposure can result in low but measurable absorption for herbal extracts, so exposure scored as low (adult). Sources: ECHA Annex VI (no harmonised classification), CIR (no reproductive safety restriction), PubChem/ECHA dossiers, EWG.
- anthemis nobilis flower extract emzirirken güvenli mi?
- No evidence of maternal reproductive or lactation toxicity or harmonised classification. No specific data showing transfer into breast milk for the extract; topical use implies low but measurable systemic exposure, so low exposure during breastfeeding is plausible. Sources: absence of reproductive/lactation hazard in ECHA/CIR listings and general safety literature (PubChem, EWG).
- anthemis nobilis flower extract bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity data identified for the extract; no harmonised classification. Because infant skin has higher permeability and surface-area-to-weight ratio, exposure rating is increased by one step versus adult (adult e=1 → infant e=2). Clinical concerns for chamomile are primarily topical allergy in sensitive individuals, not developmental toxicity. Sources: ECHA Annex VI (no classification), PubMed/CIR absence of developmental signals, EWG.
- VeriMom anthemis nobilis flower extract nasıl puanlıyor?
- VeriMom anthemis nobilis flower extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte anthemis nobilis flower extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.